glp-1 and crohn's Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review GLP-1s and Crohn's Disease: Safety,
Description
10.1210/en.2011-1485 93 NiesA
For this reason, healthcare providers carefully review each persons overall health before starting treatment and continue to monitor their progress over time
This could guide the selection of treatment and maximize therapeutic results
1 In vivo pharmacokinetic profile and in vitro activity of mGIPR-Ab
Cani PD, Everard A, Duparc T
Abrupt discontinuation produces the worst outcomes in every study that has examined it
